Sponsored

How Novel Technologies and Opioid Alternatives Can Improve Patient Outcomes

Sponsored by Takeda Pharmaceuticals

A secukinumab researcher explains why the practice may become the "next stethoscope" of medicine.

This ad was supported by Church & Dwight Co. Inc, featuring Feryal Hajee, MD.

An examination of the physical, emotional and social burden of psoriasis, and the continued need for research to advance care for patients.

Frank Trudo, MD, MBA, was recently appointed as VP, US Respiratory, Medical Affairs, at AstraZeneca.

Results from a 2017 clinical trial indicated that the Accelerate Pheno system produced an ID result in about 1 hour and 24 minutes in 95% of runs.

The Accelerate PhenoTM system allows for pathogen identification in only 90 minutes, and is revolutionizing infectious disease diagnostics.